NCBiotech News

Verona Pharma, with U.S. headquarters in Raleigh, has clinched a $219 million deal to market its “first-in-class” drug, ensifentrine, targeting chronic obstructive pulmonary disease (COPD), in China.

With grant support from NCBiotech, engineers at Duke University have demonstrated a prototype X-ray scanning machine that reveals not just the shape of an object but its molecular composition.

Jonathan Maynard has traveled a long career path that will one day allow him to return to South Korea. And, it all started with JCC’s BioWork certificate program.

Biogen’s largest RTP facility at 5000 Davis Drive is producing the initial supplies of the company's Alzheimer’s treatment newly approved by the U.S. Food and Drug Administration.

The FDA has just granted Chimerix marketing approval for the tablet and oral suspension formulations of its smallpox treatment TEMBEXA (brincidofovir).

Bluebird bio, a gene therapy company with manufacturing facilities in Durham, is resuming clinical trials of potential therapies for two inherited blood disorders after clearance from the FDA.

North Carolina's attention-grabbing 15 life sciences company announcements so far in 2021, reflecting $2.9B+ in investment plans and 2,686 in new jobs, is on pace to surpass 2020's full-year bonanza of $3B+ in investments with plans to add 4,800+ jobs statewide.

GRAIL's new blood test that can detect more than 50 types of cancer in a single blood draw is now available in the United States with a prescription.

Thermo Fisher Scientific will begin making “hundreds of millions of doses” of Moderna's COVID-19 vaccine at its Greenville facilities this summer.

A career in biomanufacturing has many benefits including a high average starting salary, minimal training requirements, advancement opportunities, job security and lasting social impact.

Duke University’s Center for Water, Sanitation, Hygiene and Infectious Disease (WaSH-AID) is developing a ‘Smart Toilet’ that uses artificial intelligence to track bowel health and report data, which aids gastroenterologists in creating and modifying treatment plans

NCBiotech portfolio company Entegrion released results from an Italian study supporting the clinical value of using heel stick blood samples, run on its portable viscoelastic coagulation monitor, in caring for premature babies.

RTP regenerative wound-healing product developer Merakris Therapeutics is launching human testing of a liquid to treat open sores on the skin known as non-healing venous stasis ulcers

Responding to a posting by the North Carolina Biotechnology Center’s Industrial Internship Program, Madison Ponder wound up as a full-time employee at the Durham precision health startup Higgs Boson Health.

Advanced Animal Diagnostics, a Morrisville diagnostics and data systems company, has $7 million more to explore the human health applications for its technology that was originally focused only on animal health.